American Fusion Secures $1.55M in 2026 Financing, Strengthens Balance Sheet Amid Leadership Shift

  • Raised $1.55M year-to-date through prepaid warrants and equity sales, with $687K added post-quarter for testing property acquisition.
  • Total assets nearly doubled to $372K by Q3 2026, while liabilities fell 21% and stockholders’ deficit improved 34%.
  • Converted $987K in accrued compensation to Series C Convertible Preferred Stock, reducing short-term obligations.
  • Expanded patent portfolio with $167K in capitalized filing costs, reflecting new Texatron™ platform filings.
  • Appointed John Gerdin to board and promoted Brent Nelson to CEO, while securing Texas DSHS registration for Texatron™ testing.

American Fusion’s financial restructuring and leadership changes reflect a strategic pivot toward operational discipline amid the capital-intensive fusion energy sector. The $1.55M raised year-to-date underscores investor interest, but the company’s ability to convert technical milestones into commercial traction remains the critical test. With regulatory approvals in place and testing infrastructure expanding, the next phase will hinge on execution against a backdrop of recurring losses and dilution risks.

Technology Validation
The pending independent review of the Texatron™ platform will determine its technical viability and investor confidence.
Facility Execution
The pace at which North Texas facilities come online will dictate the timeline for Texatron™ testing and commercialization.
Debt-to-Equity Shift
Whether the proposed restructuring of consulting notes into Series D Preferred Stock can further reduce liabilities and stabilize governance.